We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDT
3076
John Hancock Premium Dividend Fund
PDT
$628M
$214K ﹤0.01%
+14,105
New +$218K
PRGS icon
3077
Progress Software
PRGS
$1.78B
$214K ﹤0.01%
+5,560
New +$255K
BCOV
3078
DELISTED
Brightcove, Inc.
BCOV
$214K ﹤0.01%
30,800
-12,500
-29% -$87K
MNK
3079
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$214K ﹤0.01%
+14,787
New +$267K
COHR icon
3080
Coherent
COHR
$63.6B
$212K ﹤0.01%
5,178
-6,673
-56% -$289K
MED icon
3081
Medifast
MED
$135M
$212K ﹤0.01%
+2,269
New +$170K
SMLF icon
3082
iShares US Small Cap Equity Factor ETF
SMLF
$4.28B
$212K ﹤0.01%
+5,432
New +$216K
PATI
3083
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$212K ﹤0.01%
11,428
-643
-5% -$12.1K
ACM icon
3084
Aecom
ACM
$9.42B
$211K ﹤0.01%
5,908
-178
-3% -$6.57K
CUZ icon
3085
Cousins Properties
CUZ
$4.83B
$211K ﹤0.01%
6,092
-16
-0.3% -$559
TSE
3086
DELISTED
Trinseo
TSE
$211K ﹤0.01%
+2,852
New +$225K
AFSI
3087
DELISTED
AmTrust Financial Services, Inc.
AFSI
$211K ﹤0.01%
17,127
-8,543
-33% -$107K
BATRA icon
3088
Atlanta Braves Holdings Series A
BATRA
$3.42B
$210K ﹤0.01%
+9,235
New +$214K
BAP icon
3089
Credicorp
BAP
$30.4B
$209K ﹤0.01%
920
-298
-24% -$66.2K
DEW icon
3090
WisdomTree Global High Dividend Fund
DEW
$155M
$209K ﹤0.01%
4,493
-1,000
-18% -$48.2K
FREL icon
3091
Fidelity MSCI Real Estate Index ETF
FREL
$1.47B
$209K ﹤0.01%
9,151
-5,066
-36% -$117K
JELD icon
3092
JELD-WEN Holding
JELD
$162M
$208K ﹤0.01%
6,800
-36,646
-84% -$1.33M
VTWG icon
3093
Vanguard Russell 2000 Growth ETF
VTWG
$1.54B
$208K ﹤0.01%
1,503
-2,192
-59% -$306K
ANIK icon
3094
Anika Therapeutics
ANIK
$277M
$207K ﹤0.01%
+4,160
New +$235K
NAN icon
3095
Nuveen New York Quality Municipal Income Fund
NAN
$373M
$207K ﹤0.01%
16,304
-1,100
-6% -$14.5K
SOR
3096
Source Capital
SOR
$383M
$207K ﹤0.01%
+5,192
New +$214K
TMO icon
3097
CALL
Thermo Fisher Scientific
TMO
$222B
$206K ﹤0.01%
+2,500
New +$525K
BWP
3098
DELISTED
Boardwalk Pipeline Partners
BWP
$206K ﹤0.01%
+20,275
New +$241K
ATEX icon
3099
Anterix
ATEX
$1.81B
$205K ﹤0.01%
6,855
-900
-12% -$30.1K
MZTI
3100
The Marzetti Company
MZTI
$3.13B
$205K ﹤0.01%
1,665
-467
-22% -$57.7K

Similar funds

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.